Collagen Diseases  >>  FR104  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
FR104 / OSE Immunotherapeutics, Asahi Kasei
NCT02800811: Safety, Tolerability, PK, PD, and Immunogenicity of Single and Multiple Ascending Intravenous Doses of FR104

Completed
1
64
Europe
FR104, Placebo
OSE Immunotherapeutics
Rheumatoid Arthritis, Complication of Transplant
06/16
07/16

Download Options